Arrow Therapeutics Limited
Records under this name other than patents Arrow Therapeutics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Arrow Therapeutics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,853,204 | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein Lapsed on the fee record Ended Oct 7, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 7, 2018 | USPTO record |
| US 7,582,624 | Benzodiazepine derivatives and pharmaceutical compositions containing them Lapsed on the fee record Ended Sep 1, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 1, 2017 | USPTO record |
| US 8,119,630 | Benzodiazepine derivatives and pharmaceutical compositions containing them Lapsed on the fee record Ended Feb 21, 2016 · USPTO record | Lapsed on the fee record | Ended Feb 21, 2016 | USPTO record |
| US 8,039,616 | Benzodiazepine Derivatives for Treating Hepatitis C Infection Lapsed on the fee record Ended Oct 18, 2015 · High confidence | Lapsed on the fee record | Ended Oct 18, 2015 | High confidence |
| US 8,008,303 | Biphenyl Derivatives and Their Use in Treating Hepatitis C Lapsed on the fee record Ended Aug 30, 2015 · High confidence | Lapsed on the fee record | Ended Aug 30, 2015 | High confidence |
| US 6,406,878 | Methods for identifying enzyme inhibitors Lapsed on the fee record Ended Jun 18, 2006 · USPTO record | Lapsed on the fee record | Ended Jun 18, 2006 | USPTO record |